151. Resveratrol inhibits ACHN cells via regulation of histone acetylation
- Author
-
Lingyan Chen, Wenjing Wang, Peizheng Lin, and Lili Dai
- Subjects
Functional role ,renal cell carcinoma ,endocrine system diseases ,Cell Survival ,proliferation ,mmp-2/-9 ,Pharmaceutical Science ,RM1-950 ,Resveratrol ,urologic and male genital diseases ,030226 pharmacology & pharmacy ,01 natural sciences ,Histones ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Movement ,Renal cell carcinoma ,Cell Line, Tumor ,Drug Discovery ,medicine ,Humans ,Carcinoma, Renal Cell ,neoplasms ,Pharmacology ,biology ,organic chemicals ,Cell Cycle ,Acetylation ,General Medicine ,medicine.disease ,Kidney Neoplasms ,female genital diseases and pregnancy complications ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Histone ,Matrix Metalloproteinase 9 ,Complementary and alternative medicine ,chemistry ,Cancer research ,biology.protein ,Matrix Metalloproteinase 2 ,Molecular Medicine ,Therapeutics. Pharmacology ,Research Article - Abstract
Context: The relationship between resveratrol and histone acetylation in renal cell carcinoma (RCC) has not yet been reported. Objective: To explore the functional role of resveratrol in RCC. Materials and methods: Functional experiments were performed to determine proliferatio n of ACHN cells with treatment of resveratrol (0, 7.8125, 15.625, 31.25 and 62.5 μg/mL, for 12, 24 and 48 h of culture) or 0.1 μM SAHA. The enzyme activities of MMP-2/-9 were measured by gelatine zymography and histone acetylation by Western blot. Results: When the cells were treated with 15.625, 31.25 and 62.5 μg/mL resveratrol, ACHN cells viability was 73.2 ± 3.5%, 61.4 ± 3.1%, 50.2 ± 4.7% for 12 h, 62.7 ± 4.5%, 52.4 ± 5.5%, 40.2 ± 3.8% for 24 h, and 60.8 ± 3.7%, 39.4 ± 5.1%, 37.6 ± 2.7% for 48 h, and the wound closure (%) of migration was increased from 0.6 to 0.7, 0.85, 0.9 for 12 h and from 0.23 to 0.3, 0.48, 0.59 for 24 h. The invasion rate was 8.5 ± 0.9%, 7.4 ± 0.3% and 5.8 ± 0.6%, and cell cycle was arrested at G1 from 42.5 ± 2.9% to 55.3 ± 5.7%, 59.8 ± 3.4%, 68.7 ± 4.6%. MMP-2/-9 expression (p
- Published
- 2020